BEGIN:VCALENDAR PRODID:-//Microsoft Corporation//Outlook 16.0 MIMEDIR//EN VERSION:2.0 METHOD:REQUEST X-MS-OLK-FORCEINSPECTOROPEN:TRUE BEGIN:VTIMEZONE TZID:Eastern Standard Time BEGIN:STANDARD DTSTART:16011104T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 END:STANDARD BEGIN:DAYLIGHT DTSTART:16010311T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT ATTENDEE;CN="Yu, Grace";RSVP=TRUE:mailto:Grace.Yu@childrens.harvard.edu ATTENDEE;CN="Baker, Greg";RSVP=TRUE:mailto:Gregory.Baker@childrens.harvard. edu ATTENDEE;CN=GSD-DL;RSVP=TRUE:mailto:GSD-DL@childrens.harvard.edu ATTENDEE;CN=FellowsClinical-dl;RSVP=TRUE:mailto:FellowsClinical-dl@children s.harvard.edu ATTENDEE;CN=MARCOM-dl;RSVP=TRUE:mailto:MARCOM-dl@childrens.harvard.edu ATTENDEE;CN=TIDO-dl;RSVP=TRUE:mailto:TIDO-dl@childrens.harvard.edu ATTENDEE;CN="MedicalDevicesInterest Group-DL";RSVP=TRUE:mailto:MedicalDevic esInterestGroup-DL@childrens.harvard.edu ATTENDEE;CN="Research_Dept Heads-dl";RSVP=TRUE:mailto:Research_DeptHeads-dl @childrens.harvard.edu ATTENDEE;CN=Research_PIs-dl;RSVP=TRUE:mailto:Research_PIs-dl@childrens.harv ard.edu ATTENDEE;CN="Research_Department Administrators-dl";RSVP=TRUE:mailto:Resear ch_DepartmentAdministrators-dl@childrens.harvard.edu ATTENDEE;CN=Research_Notifications-dl;RSVP=TRUE:mailto:Research_Notificatio ns-dl@childrens.harvard.edu ATTENDEE;CN=DivisionChiefs-dl;RSVP=TRUE:mailto:DivisionChiefs-dl@childrens. harvard.edu ATTENDEE;CN="Research_Research Administration-dl";RSVP=TRUE:mailto:Research _ResearchAdministration-dl@childrens.harvard.edu ATTENDEE;CN=FellowsResearch-dl;RSVP=TRUE:mailto:FellowsResearch-dl@children s.harvard.edu ATTENDEE;CN=chiefsofservice-dl;RSVP=TRUE:mailto:chiefsofservice-dl@children s.harvard.edu ATTENDEE;CN="Research Managers/Directors-dl";RSVP=TRUE:mailto:ResearchManag ers_Directors-dl@childrens.harvard.edu ATTENDEE;CN=IF-dl;RSVP=TRUE:mailto:IF-dl@childrens.harvard.edu ATTENDEE;CN=VPsDirectorsandManagers-dl;RSVP=TRUE:mailto:vpsdirectorsandmana gers-dl@childrens.harvard.edu ATTENDEE;CN="Pain Imaging-dl";RSVP=TRUE:mailto:PainImaging-dl@childrens.har vard.edu CLASS:PUBLIC CREATED:20210427T000844Z DESCRIPTION:\n\nThe Technology Development Fund (TDF) is a seed-stage acade mic catalyst fund for BCH Principal Investigators dedicated to translating commercially promising early-stage\, academic technologies into new thera peutics\, medical devices\, and diagnostics products to benefit our patien ts and the broader public.\n\n\n\nJoin us at our info session to learn mor e!\n\n\nDate & Time\nMonday\, May 3\, 2021\n1:00 - 1:45 PM EST\n\nAgenda\n 1:00 - 1:30 PM | TDF Overview\n1:30 - 1:45 PM | Q&A\n\nZoom Information\n\ nMeeting Link: https://bostonchildrens.zoom.us/j/99254222707?pwd=L1ZDY3c0c lhEcnRpZWFwNXgrWVBmdz09 \nOne-touch Dial-in: +1-646-558-8656\,\,9925422270 7#\,\,\,\,\,\,0#\,\,931568#\n\n\nMeeting ID: 992 5422 2707\nPassword: 9315 68\n\nEWS Link: https://zoom.us/wc/99254222707/join\nIf you are unable to attend\, a recording will be made available on our website.\n\nQuestions? Email us at technology.development@childrens.harvard.edu\n\n\n\n DTEND;TZID="Eastern Standard Time":20210503T134500 DTSTAMP:20210426T144559Z DTSTART;TZID="Eastern Standard Time":20210503T130000 LAST-MODIFIED:20210427T000844Z LOCATION:https://bostonchildrens.zoom.us/j/99254222707?pwd=L1ZDY3c0clhEcnRp ZWFwNXgrWVBmdz09 ORGANIZER;CN="Technology Development Fund":mailto:Technology.Development@ch ildrens.harvard.edu PRIORITY:5 SEQUENCE:6 SUMMARY;LANGUAGE=en-us:Info Session: Technology Development Fund TRANSP:OPAQUE UID:040000008200E00074C5B7101A82E00800000000F1AB0C38BA37D701000000000000000 01000000083CED42526314740B98394531136417A X-ALT-DESC;FMTTYPE=text/html:


\n